Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MeiraGTx Holdings (MGTX) Depreciation and Depletion (2017 - 2020)

MeiraGTx Holdings posted quarterly Depreciation and Depletion of $879143.0 for Q4 2020, up 31.32% year-on-year from $669462.0 in Q1 2020, and down 17.46% on a QoQ basis from $1.1 million in Q3 2020.

MeiraGTx Holdings (MGTX) has 4 years of Depreciation and Depletion data on file, last reported at $879143.0 in Q4 2020.

  • For the quarter ending Q4 2020, Depreciation and Depletion rose 31.32% year-over-year to $879143.0; the trailing twelve-month figure through Dec 2020 stood at $3.7 million (up 65.28% YoY), and the FY2022 full-year result was $7.3 million, up 15.87% from the prior year.
  • Depreciation and Depletion for Q4 2020 stood at $879143.0, down from $1.1 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $1.1 million in Q3 2020 and bottomed at $99481.0 in Q4 2017.
  • The 4-year median for Depreciation and Depletion is $535624.5 (2018), against an average of $592691.5.
  • The widest annual swing landed in 2018, when Depreciation and Depletion surged 406.16%; it then retreated 3.52% in 2019.
  • A 4-year view of Depreciation and Depletion shows it stood at $99481.0 in 2017, then soared by 406.16% to $503534.0 in 2018, then surged by 32.95% to $669462.0 in 2019, then soared by 31.32% to $879143.0 in 2020.
  • The last three Depreciation and Depletion figures came in at $879143.0 (Q4 2020), $1.1 million (Q3 2020), and $940316.0 (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 1,395.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -
10 MeiraGTx Holdings 856.58 Mn 790.65 Mn 74.89 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2020 879,143.00
Dec 31, 2020 879,143.00
Sep 30, 2020 1.07 Mn
Sep 30, 2020 1.07 Mn
Jun 30, 2020 940,316.00
Jun 30, 2020 940,316.00
Mar 31, 2020 815,423.00
Mar 31, 2020 815,423.00
Dec 31, 2019 669,462.00
Dec 31, 2019 669,462.00
Sep 30, 2019 532,815.00
Sep 30, 2019 532,815.00
Jun 30, 2019 536,642.00
Jun 30, 2019 536,642.00
Mar 31, 2019 499,641.00
Mar 31, 2019 499,641.00
Dec 31, 2018 503,534.00
Dec 31, 2018 503,534.00
Sep 30, 2018 534,607.00
Sep 30, 2018 534,607.00
Jun 30, 2018 556,243.00
Jun 30, 2018 556,243.00
Mar 31, 2018 458,836.00
Mar 31, 2018 458,836.00
Dec 31, 2017 99,481.00
Dec 31, 2017 99,481.00
Sep 30, 2017 206,420.00
Sep 30, 2017 206,420.00